NasserAltorkiMD

PubMed

• Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer.
  Abu Nasar, Benjamin Lee, Shaikha Al-Thani, Jonathan Villena-Vargas, Sebron Harrison, Jeffrey L Port, Nasser Altorki, Oliver S Chow> ;Journal of Thoracic Disease. 2024 Mar 29
• A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer.
  Nasser K Altorki, Bhavneet Bhinder, Alain C Borczuk, Olivier Elemento, Vivek Mittal, Timothy E McGraw> ;Cell Reports. Medicine. 2024 Mar 19
• The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
  Dunne, E., Fick, C., Isbell, J., Chaft, J., Altorki, N., Park, B., Spicer, J., Forde, P., Gomez, D., Iyengar, P., Harpole, D., Stinchcombe, T., Liberman, M., Bott, M.,...> ;The Annals of Thoracic Surgery. 2024 Feb 3
• Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-...
  Thomas E Stinchcombe, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, M...> ;Journal of Clinical Oncology. 2024 Apr 1
• Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
  Madorsky Rowdo, F., Xiao, G., Khramtsova, G., Nguyen, J., Martini, R., Stonaker, B., Boateng, R., Oppong, J., Adjei, E., Awuah, B., Kyei, I., Aitpillah, F., Adinku, M....> ;Cancer Letters. 2024 Mar 1
• Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials.
  Kneuertz, P., Ferrari-Light, D., Altorki, N.> ;The Annals of Thoracic Surgery. 2024 Jan 5
• Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates...
  Altorki, N., Walsh, Z., Melms, J., Port, J., Lee, B., Nasar, A., Spinelli, C., Caprio, L., Rogava, M., Ho, P., Christos, P., Saxena, A., Elemento, O., Bhinder, B., Age...> ;Nature Communications. 2024 Jan 3
• 1 citations
  Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized ph...
  Altorki, N., Walsh, Z., Melms, J., Port, J., Lee, B., Nasar, A., Spinelli, C., Caprio, L., Rogava, M., Ho, P., Christos, P., Saxena, A., Elemento, O., Bhinder, B., Age...> ;Nature Communications. 2023 Dec 19
• Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?
  Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Benjamin Lee, Nasser Altorki, Sebron Harrison, Chow, O., Port, J.> ;The Journal of Thoracic and Cardiovascular Surgery. 2023 Nov 4
• The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of t...
  Stephanie G Worrell, Karyn A Goodman, Nasser K Altorki, Jonathan B Ashman, Traves D Crabtree, Jennifer Dorth, Scott Firestone, David H Harpole, Wayne L Hofstetter, The...> ;The Annals of Thoracic Surgery. 2024 Jan 1
• The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of t...
  Stephanie G Worrell, Karyn A Goodman, Nasser K Altorki, Jonathan B Ashman, Traves D Crabtree, Jennifer Dorth, Scott Firestone, David H Harpole, Wayne L Hofstetter, The...> ;Practical Radiation Oncology. 2023 Nov 2
• 1 citations
  Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomize...
  Caicun Zhou, Minu K Srivastava, Hao Xu, Enriqueta Felip, Heather Wakelee, Nasser Altorki, Martin Reck, Rüdiger Liersch, Anna Kryzhanivska, Satoshi Oizumi, Hiroshi Tana...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
• Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade.
  Geoffrey J Markowitz, Yi Ban, Diamile A Tavarez, Liron Yoffe, Enrique Podaza, Yongfeng He, Mitchell T Martin, Michael J P Crowley, Tito A Sandoval, Dingcheng Gao, M La...> ;Research Square. 2023 Sep 21
• Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821?
  Nasser K Altorki, Oliver S Chow> ;The Journal of Thoracic and Cardiovascular Surgery. 2024 Jan 1
• 3 citations
  International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
  Sanja Dacic, William Travis, Mary Redman, Anjali Saqi, Wendy A Cooper, Alain Borczuk, Jin-Haeng Chung, Carolyn Glass, Javier Martin Lopez, Anja C Roden, Lynette Sholl,...> ;Journal of Thoracic Oncology. 2023 Oct 1
• 4 citations
  Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).
  Nasser Altorki, Xiaofei Wang, Bryce Damman, Jennifer Mentlick, Rodney Landreneau, Dennis Wigle, David R Jones, Massimo Conti, Ahmad S Ashrafi, Moishe Liberman, Marc de...> ;The Journal of Thoracic and Cardiovascular Surgery. 2024 Jan 1
• Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
  Madorsky Rowdo, F., Xiao, G., Khramtsova, G., Nguyen, J., Olopade, O., Martini, R., Stonaker, B., Boateng, R., Oppong, J., Adjei, E., Awuah, B., Kyei, I., Aitpillah, F...> ;Biorxiv. 2023 Jun 22
• 1 citations
  Regulation of PD-L1 Trafficking from Synthesis to Degradation.
  Eyoel Yemanaberhan Lemma, Anudari Letian, Nasser K Altorki, Timothy E McGraw> ;Cancer Immunology Research. 2023 Jul 5
• 2 citations
  Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer.
  Benjamin E Lee, Nasser Altorki> ;Cancers. 2023 May 25
• 11 citations
  Improving outcomes in patients with oesophageal cancer.
  Manish A Shah, Nasser Altorki, Pretish Patel, Sebron Harrison, Adam Bass, Julian A Abrams> ;Nature Reviews. Clinical Oncology. 2023 Jun 1
• 1 citations
  Volume outcome relationship in post-esophagectomy leak: A systematic review and meta-analysis.
  Mohamed Rahouma, Massimo Baudo, Nathan Mynard, Mohamed Kamel, Faiza M Khan, Shon Shmushkevich, Mohamed Hosny, Anas Dabsha, Sherif Khairallah, Michelle Demetres, Reda S...> ;International Journal of Surgery. 2023 Apr 14
• Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP Code.
  Jack Wish, Jonathan Villena-Vargas, Sebron Harrison, Ben Lee, Oliver Chow, Jeffrey Port, Nasser Altorki, Brendon M Stiles> ;World Journal of Surgery. 2023 Aug 1
• 1 citations
  Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells.
  Anudari Letian, Eyoel Yemanaberhan Lemma, Paola Cavaliere, Noah Dephoure, Nasser K Altorki, Timothy E McGraw> ;Cell Communication and Signaling. 2023 Mar 13
• 10 citations
  A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease.
  Samir Rustam, Yang Hu, Seyed Babak Mahjour, Andre F Rendeiro, Hiranmayi Ravichandran, Andreacarola Urso, Frank D'Ovidio, Fernando J Martinez, Nasser K Altorki, Bradley...> ;American Journal of Respiratory and Critical Care Medicine. 2023 May 1
• 3 citations
  Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial.
  Jay M Lee, Eric Vallières, Beiying Ding, Ann Johnson, Jan Bhagwakar, Sanam Rashidi, Qian Cindy Zhu, Barbara J Gitlitz, Benny Weksler, Kimberly Costas, Nasser Altorki> ;The Journal of Thoracic and Cardiovascular Surgery. 2023 Sep 1
• Join now to see all